Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP)
ورودیهای بالینی بیمار
حداقل ۷۰ — حداکثر ۸۹ • واحد: years
حداقل ۸۰ — حداکثر ۲۵۰ • واحد: mmHg
حداقل ۲ — حداکثر ۱۲ • واحد: mmol/L
حداقل ۰.۵ — حداکثر ۳.۵ • واحد: mmol/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low to Moderate Risk0–7.5
- High Risk7.5–15
- Very High Risk15–100
The Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) calculator is designed for bedside predicting 5-year and 10-year cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) risk in individuals aged 70 years and older without prior cardiovascular disease, accounting for competing risks in clinical practice.
Clinical Guidelines & Evidence
Predicts 5-year and 10-year cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) risk in individuals aged 70 years and older without prior cardiovascular disease, accounting for competing risks.
Clinical Indication
The Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) is indicated for bedside clinical practice to support Predicts 5-year and 10-year cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) risk in individuals aged 70 years and older without prior cardiovascular disease, accounting for competing risks.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Consider frailty, cognitive function, and patient preferences in treatment decisions.
Competing risk-adjusted model accounting for non-CVD mortality, with age interactions and attenuation of risk factor gradients in older persons
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Biological sex |
| age | integer | Yes | Age in years(years) |
| diabetes | string | Yes | Diabetes status |
| smoking | string | Yes | Current smoking status |
| systolic_bp | integer | Yes | Systolic blood pressure(mmHg) |
| total_cholesterol | float | Yes | Total cholesterol(mmol/L) |
| hdl_cholesterol | float | Yes | HDL cholesterol(mmol/L) |
| risk_region | string | Yes | Cardiovascular risk region based on country |
| time_horizon | string | Yes | Risk prediction time horizon |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–7.5 | Low to Moderate Risk | Low to moderate cardiovascular risk (<7.5%) |
| 7.5–15 | High Risk | High cardiovascular risk (7.5-15%) |
| 15–100 | Very High Risk | Very high cardiovascular risk (≥15%) |
Evidence-Based References (EBM)
- SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.DOI: 10.1093/eurheartj/ehab312
- de Vries TI, Cooney MT, Selmer RM, Hageman SHJ, Pennells L, Wood A, et al. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021 Jul 1;42(25):2455-2467.
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.DOI: 10.1093/eurheartj/ehab484